Jeff Morhet
is Chairman & CEO of InNexus Biotechnology, (Toronto Stock Exchange:
IXS.V), a publicly traded drug development company based
in British Columbia, Canada with laboratories in Scottsdale, Arizona
His experience spans pharmaceutical product development,
manufacturing, commercialization and working with the FDA for drug
applications. He has launched multiple biotech/pharma companies and
believes that a strong network in Arizona for life sciences,
biotech and healthcare will greatly enhance the state’s
opportunity to be a leading bioscience economy.
Jeffrey Jacob
is a Founder and CEO of Systems Medicine LLC, a wholly owned subsidiary
of Cell Therapeutics, Inc., and is also the principal of Tucson Pharma
Ventures LLC, an Arizona-based biopharmaceutical development. He is a
founding Board Member and served as the Acting Chief Program Officer of
the CPATH Institute, a startup nonprofit Institute co-founded by the
FDA, University of Arizona, and SRI International to accelerate drug
development. Jeffrey also spent 16 years with Research Corporation
Technologies (RCT) and has a Masters degree in engineering and a
Masters degree in Technology and Policy from Massachusetts Institute of
Technology. His bachelor’s degree in engineering was awarded from the
University of Arizona.
Nina Ossanna plays
a dual role at the University of Arizona, in the UA’s Office of
Technology Transfer and as the Director of Business Development for the
BIO5 Institute. In addition, she is a mentor in the Eller College's
McGuire Entrepreneurship Program and serves as the Chairman of the
Southern Arizona Bioindustry Association and brings a wealth of
experience in intellectual property, technology transfer and early
stage commercialization to the University. Prior to joining the UA,
she was Senior Director of Business Development and Intellectual
Property and Corporate Secretary for ImaRx Therapeutics, a Tucson
biopharmaceutical company. Before returning to Tucson, Dr. Ossanna
spent 8 years at Johns Hopkins University School of Medicine’s Office
of Technology Licensing, including serving as the director of that
office. She is a former patent examiner in the biotechnology arts at
the USPTO and is a registered patent agent. Dr. Ossanna earned her
Ph.D. in Molecular Biology from the UA
Kealey Zeigler is the “Hostess with the Mostess” and the Event Coordinator of
ThirdBio. We thank her for her time, energy and dedication as we
couldn’t operate without her.
